LeapFrog Investments sponsored a $61 million Series B financing for Redcliffe Lifetech, an India-based diagnostics platform.
The funds will be used to extend Redcliffe Lifetech’s geographic reach throughout India, with an emphasis on its direct-to-consumer diagnostics network. The money will also be used to expand the company’s product offerings, which will include imaging, illness data profiling, and lifestyle management.
Redcliffe Lifetech provides over 3,500 pathologies and specialist testing, including genetics, at low pricing. The company has 22 labs in 14 locations across India.
“This investment will help us scale rapidly to achieve our goal to reach 500 million Indians within the next five years,” said Dheeraj Jain, founder of Redcliffe Lifetech.
